Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-18-175433
Filing Date
2018-05-25
Accepted
2018-05-25 16:48:09
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B4 d522368d424b4.htm 424B4 1963853
2 GRAPHIC g522368g19c10.jpg GRAPHIC 130605
3 GRAPHIC g522368g20i14.jpg GRAPHIC 131580
4 GRAPHIC g522368g29x80.jpg GRAPHIC 136035
5 GRAPHIC g522368g43z47.jpg GRAPHIC 83256
6 GRAPHIC g522368g47p15.jpg GRAPHIC 159013
7 GRAPHIC g522368g73n73.jpg GRAPHIC 47677
  Complete submission text file 0001193125-18-175433.txt   2913609
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-224582 | Film No.: 18862174
SIC: 2834 Pharmaceutical Preparations